在患有过敏症的儿童中Omalizumab的安全性和耐受性 (
Dandan Lang1, Zhengmin Liu2, Dejun Li3
1Department of Paediatrics, Zhuhai People's Hospital, Zhuhai Hospital of Jinan University, The First Hospital of the Faculty of Medicine of Macau University of Science and Technology, 519000 Zhuhai, Guangdong, China.
Discovery medicine
|June 5, 2023
概括
奥马利祖马布显著提高了过敏喘治疗的疗效,并减少了儿童的恶化. 这种疗法还可以减少严重的不良反应而不会增加整体风险,提供更安全的治疗选择.
科学领域:
- 儿科过敏和免疫学
- 呼吸系统医学 呼吸系统医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 儿童的过敏性喘 (AA) 通常与免疫球蛋白E (IgE) 有关.
- 目前的治疗方法可能有局限性,需要探索向治疗方法.
- 奥马利祖马布通过结合IgE提供了有针对性的方法.
结论:
- 将奥马利祖马布添加到葡萄糖皮质激素治疗中,可以提高儿科IgE介导喘治疗的有效性.
- 奥马利祖马布可以降低喘严重恶化的可能性.
- 这种治疗与较低的严重不良反应发生率有关.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
358
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
358
Antiasthma Drugs: Leukotriene Modifiers
375
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
375
Allergic Drug Reactions
900
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
900
Allergic Reactions
27.9K
Overview
27.9K
Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Asthma: Pathogenesis and Management
462
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
462


